home / stock / snynf / snynf news


SNYNF News and Press, Sanofi From 05/22/24

Stock Information

Company Name: Sanofi
Stock Symbol: SNYNF
Market: OTC
Website: sanofi.com

Menu

SNYNF SNYNF Quote SNYNF Short SNYNF News SNYNF Articles SNYNF Message Board
Get SNYNF Alerts

News, Short Squeeze, Breakout and More Instantly...

SNYNF - Bristol Myers, Sanofi liability in Hawaii Plavix litigation tops $900M

2024-05-22 15:38:02 ET More on Bristol-Myers, Sanofi, etc. Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript) Brist...

SNYNF - Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration

Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Paris, New York, N.Y., and San Francisco, CA, May 21, 2024 . Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patien...

SNYNF - Pfizer: Best Trading Momentum Since 2021 And 6% Yield

2024-05-15 08:45:36 ET Summary Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist. PFE sto...

SNYNF - Evercore says biotech 'winter is finally thawing'

2024-05-14 11:24:32 ET More on BioNTech, Moderna, etc. BioNTech SE 2024 Q1 - Results - Earnings Call Presentation BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks Moderna announces del...

SNYNF - Novavax's sudden rise burns short sellers: report

2024-05-11 07:59:50 ET More on Novavax Novavax Ditches 'Going Concern,' Embraces Sanofi Safety Net (Rating Upgrade) Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference -...

SNYNF - AI-discovered drugs have an 80%-90% success rate: study

2024-05-10 14:13:46 ET More on Alphabet, Recursion, etc. Recursion Pharmaceuticals, Inc. (RXRX) Q1 2024 Earnings Call Transcript Bronte Capital - Alphabet: Could Not Find Anything We Liked More Google: The Recent Surge Is Far From Over CrowdStrike, Google exp...

SNYNF - Novavax Ditches 'Going Concern,' Embraces Sanofi Safety Net (Rating Upgrade)

2024-05-10 13:50:51 ET Summary Novavax, Inc.'s Sanofi partnership provides much-needed financial support via upfront and milestone payments, stabilizing its finances. Combination vaccines are set to be an essential market, but competitors like Pfizer and Moderna are further along....

SNYNF - Novavax hits a 52-week high as Sanofi deal prompts J.P. Morgan upgrade

2024-05-10 11:15:35 ET More on Novavax Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference - (Transcript) Novavax: Another Day Older And Deeper In Novavax surges...

SNYNF - Novavax surges as Sanofi COVID vaccine deal boosts outlook

2024-05-10 06:59:03 ET More on Novavax Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference - (Transcript) Novavax: Another Day Older And Deeper In Biggest stock ...

SNYNF - Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines

Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strengt...

Previous 10 Next 10